"Natular larvicides were developed with the Aedes aegypti mosquito in mind," said David McLaughlin, VP of Marketing for Clarke. "This container-breeding mosquito can transmit diseases like Zika, dengue and chikungunya – and Natular DT tablets are proven effective at controlling breeding of these mosquitoes."
Natular larvicides – including the Natular DT tablet -- were awarded the U.S. EPA Presidential Green Chemistry Challenge award in 2010, and the Natular line of products were the first larvicides evaluated as reduced risk by the U.S. EPA.
"The battle against Zika is fought in backyards," said McLaughlin. "Zika mosquitoes do not travel far from where they breed, so by treating breeding sites like fish ponds, rain barrels and other containers, homeowners can stop mosquitoes from breeding and provide a greater level of protection to their families and community."
Municipalities and health departments in Florida distributed Natular DT tablets in packages known as Z-Kits to homeowners in 2016 to help protect residents from the threat of mosquito-borne diseases like Zika. The Natular DT tablet features an effervescent layer that immediately kills mosquito larvae and a slow-release layer offers long-lasting control for up to 60 days.
About Clarke Consumer Products
Clarke Consumer Products, Inc., is one of five companies in The Clarke Group. The Clarke Group is the leading provider of mosquito control products and services in the United States, and product sales in over 45 countries internationally. A family-owned business since 1946, our mission is to make communities more livable, safe and comfortable for families around the world. We do this by pioneering, developing and delivering environmentally responsible mosquito control and aquatic services to help prevent disease, control nuisances and create healthy waterways. www.clarke.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/natular-dt-mosquito-larvicide-tablets-now-available-direct-to-homeowners-300405261.html